Glycobiology in Medicine

Area of Science:

• Biochemistry
• Glycobiology
• Molecular Biology

Background:

• Glycoconjugates, encompassing carbohydrates linked to proteins or lipids, are vital in numerous biological reactions, including cellular recognition and enzyme targeting.
• Aberrations in glycoconjugate structures are associated with various diseases, such as cancer and glycoprotein syndromes, due to altered cell surface expression.
• Carbohydrate-binding proteins (lectins) mediate many biological interactions, and their dysfunction can lead to pathological conditions like I-cell disease.

Purpose of the Study:

• To highlight the critical roles of glycoconjugates in normal biological functions.
• To underscore the significance of aberrant glycoconjugate structures in disease pathogenesis, particularly in cancer.
• To explore the therapeutic and diagnostic potential of targeting carbohydrate structures and receptors.

Main Methods:

• Review of existing literature on glycoconjugate function and disease association.
• Analysis of the role of specific glycoconjugates (e.g., sialyl Lewis(x), mannose-6-phosphate) in biological processes.
• Examination of pathogen-carbohydrate interactions and their implications for invasion and vaccine development.

Main Results:

• Glycoconjugates on tumor cells exhibit quantitative differences compared to normal cells.
• Deficiencies in carbohydrate structures lead to known glycoprotein syndromes.
• Pathogens utilize carbohydrates as recognition markers for cellular invasion.
• Carbohydrate receptors offer potential targets for drug, antibody, and DNA delivery.

Conclusions:

• Glycoconjugates are fundamental to biological recognition and cellular processes.
• Alterations in glycoconjugate structure and expression are hallmarks of disease and can be exploited for therapeutic strategies.
• The specific roles of carbohydrates in host-pathogen interactions and disease progression warrant further investigation for vaccine and drug development.